The contribution of dietary advanced glycation end‐products and genetic risk in the development of inflammatory bowel disease: a prospective cohort study

Aug 23, 2024Alimentary pharmacology & therapeutics

How Diet-Related Harmful Compounds and Genetic Risk May Influence the Development of Inflammatory Bowel Disease

AI simplified

Abstract

During a median follow-up of 13.72 years, 671 participants developed inflammatory bowel disease (IBD).

  • Dietary intake of Nε-(1-carboxyethyl)-lysine (CEL) is associated with an increased risk of IBD (HR = 1.09).
  • CEL intake is also linked to a heightened risk of Crohn's disease (CD) (HR = 1.18).
  • The increased risk of IBD associated with CEL is particularly notable among participants who are overweight, physically inactive, and non-smokers.
  • Among individuals at high genetic risk for CD, higher risks were observed for other dietary AGEs, including CML and MG-H1.
  • No significant association was found between dietary AGEs and ulcerative colitis (UC) risk, regardless of genetic predisposition.

AI simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free